ANNOUNCEMENT
Pengujian Produk Rapid Test Diagnostic Test (RDT) Antigen Covid-19
On February 14, 2022, the Ministry of Health of the Republic of Indonesia, stated that for new applications and to extend the registration for a distribution permit for domestic and imported Covid-19 RDT Products, you must attach the results of a minimum validation test from 1 (one) designated Test Laboratory in accordance with the Decree of the Minister of Health. republic of Indonesia number HK.01.07/MENKES/477/2021 concerning the Testing Laboratory for the Validity of the Rapid Diagnostic Test of Antigen (Rdt-Ag). The validity period of the validation test results is 3 (three) months from the submission of a new and extended application.
Read more at:REGALKES REGALKES
Artikel Lainnya
-
GDPMD and Impact on Medical Device Registration in Indonesia
-
Transition from Waarmerking to Notarial Deed: New Agreement Validation for PJT and Companies in Medical Device Distribution
-
Understanding GB 9706.1-2020: The Chinese Standard Equivalent to IEC 60601.1 Part 1
-
Indonesia Ministry of Health Mandates GDPMD Certification for E-Catalogue Enrolment in 2025
-
INAPROC Implementation for Electronic Catalog Providers in 2025
English 
Indonesian